iCardiac Technologies, Inc. and Pfizer have into a multiyear research alliance to develop and validate advanced ECG ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
Jan. 29, 2007 — Novadaq Technologies Inc. and Apple Inc. presented new technologies to about 100 heart surgeons Sunday ...
Jan. 25, 2007 — Research emerging this week from a Harvard researcher claims there is no evidence that statins prevent ...
Jan. 19, 2007 — Daiichi Sankyo Co., Ltd. and Eli Lilly and Co. have announced completion of patient enrollment in their ...
Jan 11, 2007 — FDA approval last week of Anthera’s Investigational New Drug (IND) application for its lead ...
Jan. 5, 2007 — An announcement from AstraZeneca is expected soon about the company’s experimental heart drug AGI ...
A review by physicians at Tulane University School of Public Health and Tropical Medicine shows that Vitamin B12 ...
Heartwire cites results of a new study finding that current heart-failure performance measures, with the exception of ...
Taking anti-platelet medication longer than current recommendations may lower heart attack or death risks for patients ...
The FDA was notified on Dec. 2 that Pfizer will suspend a large, Phase 3 trial evaluating the investigational ...
CV Therapeutics has announced it will file a new drug application to the FDA for its regadenoson agent in mid-2007 ...
The Society for Cardiac Angiography and Interventions (SCAI) has extended the abstract deadline for its 30th Annual ...
Houston based ThromboVision, Inc. has won the first annual Michael E. DeBakey Life Science Award, which carries a ...
An aspirin a day really does keep heart attack and stroke away for women, yet fewer than half of American women ...
San Francisco-based McKesson announced it has agreed to purchase Per-Se Technologies, Alpharetta, Ga., in a deal ...